• Scientific publication:

Ruzsics, Z., Hoffmann, K., Riedl, A. Krawczyk, A., Widera, M. Sertznig, H., Schipper, L., Kapper-Falcone, V., Debreczeny, M., Ernst, W., Grabherr, R., Hengel, H., Harant H. (2020) A Novel, Broad-Acting Peptide Inhibitor of Double-Stranded DNA Virus Gene Expression and Replication. Frontiers in Microbiology 11, 2934, doi:10.3389/fmicb.2020.601555;
Link caption

• Scientific publication:

Harant, H., Höfinger, S., Kricek, F., Ruf, C., Ruzsics, Z., Hengel, H., Lindley, I.J.D. (2021) The Peptide TAT-I24 with Antiviral Activity against DNA

Viruses Binds Double-Stranded DNA with High Affinity. Biologics 2021, 1, 41-60, https://doi.org/10.3390/biologics1010003

Link caption

• US Patent 11,034,726 granted on June 15, 2021

• EU Patent 3684783 granted on September 15, 2021

• Scientific publication:

Harant, H. (2022) Selective Inhibition of Murine Cytomegalovirus Viral Gene Expression by the Antiviral Peptide TAT-I24.

Int. J. Mol. Sci. 23(13), 7246, https://doi.org/10.3390/ijms23137246

Link caption

• JP Patent 2020-537870 granted on April 04, 2023

• CN Patent ZL 2018 8 0061980.2 granted on October 24, 2023

• Scientific publication:

Ziu T, Sambur E, Ruzsics Z, Hengel H, Grabherr R, Höfinger S, Harant H. (2024) In Vitro Profiling of the Antiviral Peptide TAT-I24. International Journal of Molecular Sciences 25(19):10463. https://doi.org/10.3390/ijms251910463

Link caption